Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 10904508)

1.

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D.

JAMA. 2000 Jul 26;284(4):450-6.

PMID:
10904508
2.

Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.

McMahon BJ, Bruden D, Bruce MG, Livingston S, Christensen C, Homan C, Hennessy TW, Williams J, Sullivan D, Rosen HR, Gretch D.

Gastroenterology. 2010 Mar;138(3):922-31.e1. doi: 10.1053/j.gastro.2009.10.056. Epub 2009 Nov 10.

PMID:
19909749
3.

Hepatitis C virus reinfection in injection drug users.

Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW.

Hepatology. 2006 Nov;44(5):1139-45.

PMID:
17058216
4.

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.

Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Moore RD, Thomas DL, Sulkowski MS.

JAMA. 2012 Jul 25;308(4):370-8. doi: 10.1001/jama.2012.7844.

5.

Hepatitis C virus load and survival among injection drug users in the United States.

Hisada M, Chatterjee N, Kalaylioglu Z, Battjes RJ, Goedert JJ.

Hepatology. 2005 Dec;42(6):1446-52.

PMID:
16317675
6.

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.

Peters L, Mocroft A, Soriano V, Rockstroh JK, Kirkby N, Reiss P, Katlama C, Zakharova N, Flisiak R, Lundgren JD; EuroSIDA in EuroCoord.

HIV Med. 2014 Nov;15(10):615-20. doi: 10.1111/hiv.12160. Epub 2014 May 11.

PMID:
24814468
7.

Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection.

Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP.

Clin Infect Dis. 2013 Feb;56(3):405-13. doi: 10.1093/cid/cis921. Epub 2012 Oct 22.

8.

Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.

Goedert JJ, Hatzakis A, Sherman KE, Eyster ME; Multicenter Hemophilia Cohort Study.

J Infect Dis. 2001 Nov 1;184(9):1202-5. Epub 2001 Sep 13.

9.

End-stage liver disease in persons with hemophilia and transfusion-associated infections.

Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC 2nd, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A.

Blood. 2002 Sep 1;100(5):1584-9.

10.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord.

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.

PMID:
23583272
11.

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2008 Nov 1;198(9):1337-44. doi: 10.1086/592171.

12.

45-year follow-up of hepatitis C virus infection in healthy young adults.

Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, Johnson LD, Lee SR, Kaplan EL.

Ann Intern Med. 2000 Jan 18;132(2):105-11.

PMID:
10644270
13.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

14.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

15.

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP.

J Infect Dis. 2009 Oct 15;200(8):1216-26. doi: 10.1086/605947.

16.

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.

Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, Grzeszczuk A, Sambatakou H, Mocroft A, Kirk O; EuroSIDA in EuroCoord.

AIDS. 2012 Sep 24;26(15):1917-26.

PMID:
22781222
17.

HIV and HCV co-infection: situation at six French university hospitals in the year 2000.

Buffet-Janvresse C, Peigue-Lafeuille H, Benichou J, Vabret A, Branger M, Trimoulet P, Goria O, Laurichesse H, Abbed A, Verdon R, Bouvet E, Lafon ME, Dussaix E, Cormerais L, Dupon M, Henquell C, Josse A, Lagoutte P, Lariven S, LeGac S, Riachi G, Verdon R, Vittecoq D; HIV-HCV Cohort Study Group.

J Med Virol. 2003 Jan;69(1):7-17.

PMID:
12436472
18.

Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.

Clausen LN, Weis N, Schønning K, Fenger M, Krarup H, Bukh J, Benfield T.

Scand J Infect Dis. 2011 Oct;43(10):798-803. doi: 10.3109/00365548.2011.589077. Epub 2011 Jul 5.

PMID:
21728744
19.

HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.

Kirk GD, Mehta SH, Astemborski J, Galai N, Washington J, Higgins Y, Balagopal A, Thomas DL.

Ann Intern Med. 2013 May 7;158(9):658-66. doi: 10.7326/0003-4819-158-9-201305070-00604.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk